149 related articles for article (PubMed ID: 16542739)
1. Identification and regulation of novel PPAR-gamma splice variants in human THP-1 macrophages.
Chen Y; Jimenez AR; Medh JD
Biochim Biophys Acta; 2006; 1759(1-2):32-43. PubMed ID: 16542739
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of four novel peroxisome proliferator activated receptor-gamma splice variants in monkey macrophages.
Zhou J; Wilson KM; Medh JD
Biochem Biophys Res Commun; 2002 Apr; 293(1):274-83. PubMed ID: 12054596
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
[TBL] [Abstract][Full Text] [Related]
4. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
[TBL] [Abstract][Full Text] [Related]
5. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells.
Subbarayan V; Sabichi AL; Kim J; Llansa N; Logothetis CJ; Lippman SM; Menter DG
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1710-6. PubMed ID: 15533897
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
7. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
Coyle AT; O'Keeffe MB; Kinsella BT
FEBS J; 2005 Sep; 272(18):4754-73. PubMed ID: 16156795
[TBL] [Abstract][Full Text] [Related]
8. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
9. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.
Li Y; Wen X; Spataro BC; Hu K; Dai C; Liu Y
J Am Soc Nephrol; 2006 Jan; 17(1):54-65. PubMed ID: 16291834
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
Tanaka T; Fukunaga Y; Itoh H; Doi K; Yamashita J; Chun TH; Inoue M; Masatsugu K; Saito T; Sawada N; Sakaguchi S; Arai H; Nakao K
Eur J Pharmacol; 2005 Jan; 508(1-3):255-65. PubMed ID: 15680279
[TBL] [Abstract][Full Text] [Related]
11. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
Butler R; Mitchell SH; Tindall DJ; Young CY
Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel peroxisome proliferator-activated receptor-gamma (PPAR-gamma) transcriptional variants in pig and human.
Omi T; Brenig B; Spilar Kramer S; Iwamoto S; Stranzinger G; Neuenschwander S
J Anim Breed Genet; 2005 Apr; 122 Suppl 1():45-53. PubMed ID: 16130456
[TBL] [Abstract][Full Text] [Related]
13. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress.
Kim HJ; Hwang JY; Kim HJ; Choi WS; Lee JH; Kim HJ; Chang KC; Nishinaka T; Yabe-Nishimura C; Seo HG
Clin Cancer Res; 2007 May; 13(9):2577-83. PubMed ID: 17473186
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor isoform expression changes in human gestational tissues with labor at term.
Berry EB; Eykholt R; Helliwell RJ; Gilmour RS; Mitchell MD; Marvin KW
Mol Pharmacol; 2003 Dec; 64(6):1586-90. PubMed ID: 14645690
[TBL] [Abstract][Full Text] [Related]
16. Effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of retinoic acid-inducible gene-I in endothelial cells stimulated with lipopolysaccharide.
Imaizumi T; Yamashita K; Taima K; Ishikawa A; Yoshida H; Satoh K
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):46-54. PubMed ID: 16303604
[TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T
Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
[TBL] [Abstract][Full Text] [Related]
19. Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta(12,14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2.
Garcia Palacios V; Morita I; Murota S
Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):215-21. PubMed ID: 11728175
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
